Immatics (IMTX) announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer, effective immediately. Dr. Ramanan joins Immatics from Anthos Therapeutics, a Novartis (NVS) company, where he served as CFO. He will succeed Immatics’ current CFO, Arnd Christ.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMTX: